心脉医疗跌2.00%，成交额6044.41万元，主力资金净流出424.60万元

Group 1 - The core viewpoint of the news is that Xinmai Medical has experienced a decline in stock price and financial performance, with a notable drop in net profit despite a slight increase in revenue [1][2]. - As of November 4, Xinmai Medical's stock price decreased by 2.00% to 100.20 CNY per share, with a market capitalization of 12.351 billion CNY [1]. - The company has seen a year-to-date stock price decline of 7.42%, with a 3.73% drop over the last five trading days and a 10.67% decline over the last 60 days [1]. Group 2 - For the period from January to September 2025, Xinmai Medical reported a revenue of 1.015 billion CNY, representing a year-on-year growth of 4.66%, while the net profit attributable to shareholders decreased by 22.46% to 429 million CNY [2]. - The company has distributed a total of 1.079 billion CNY in dividends since its A-share listing, with 817 million CNY distributed over the past three years [3]. - As of September 30, 2025, the number of shareholders decreased by 8.73% to 16,000, while the average number of circulating shares per person increased by 9.56% to 7,708 shares [2].